Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Scrutiny of High Drug Costs Require Specialty Pharmacy Strategy Shift
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies may need to alter current strategies with increasing attention on high drug costs.
Recent Videos
Related Content
